Loading clinical trials...
Loading clinical trials...
Phase III Randomized Double-Blind Trial of Bepanthen® Cream Versus Cetomacrogol Cream in the Prevention of Papulopustular Eruption in Patients Receiving Epidermal Growth Factor Receptor Inhibitors (EGFRI): BeCet
Conditions
Interventions
dexpanthenol 5% cream
Cetomacrogol cream
Locations
6
Netherlands
Medisch Centrum Alkmaar
Alkmaar, Netherlands
Deventer ziekenhuis
Deventer, Netherlands
Admiraal de Ruyter Hospital
Goes, Netherlands
Leiden University Medical Centre
Leiden, Netherlands
Waterland Hospital
Purmerend, Netherlands
Zaans Medisch Centrum
Zaandam, Netherlands
Start Date
September 1, 2010
Primary Completion Date
December 1, 2016
Completion Date
March 1, 2017
Last Updated
November 13, 2017
NCT04929028
NCT05198830
NCT04235764
NCT04550494
NCT03375307
NCT05245812
Lead Sponsor
Impaqtt Foundation
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions